GrowthCurve Capital's controlling investment in Revecore values the hospital revenue cycle management company in the low $500 million range, sources familiar with the deal terms tell Sarah.
Driving the news: GrowthCurve, launched less than a year ago by Sumit Rajpal, Goldman Sachs' former global co-head of merchant banking, clinched what represent's the private equity firm's debut health care deal (and third overall).
